SPDR S&P Biotech ETF (XBI) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Pfizer Gains FDA Approval for Colorectal-Cancer Treatment
WSJDec 20 15:11 ET
SPDR S&P Biotech ETF To Go Ex-Dividend On December 23rd, 2024 With 0.00269 USD Dividend Per Share
Moomoo NewsDec 20 19:40 ET
Sarepta Awarded $115.2M in Vyondys 53 Patent Case: Report
Seeking AlphaDec 20 18:00 ET
Needham Reiterates Hold on Neurocrine Biosciencesto Hold
BenzingaDec 20 10:52 ET
Neurocrine Biosciences Analyst Ratings
BenzingaDec 20 10:50 ET · Ratings
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Kevin TraversDec 20 10:29 ET

Comments

topcing

Nov 4 21:29

$SPDR S&P Biotech ETF (XBI.US)$ yea

股勇者

Oct 25 10:17

$SPDR S&P Biotech ETF (XBI.US)$ 100 month end? ok?

1

Bellaah

Sep 11 11:10

$SPDR S&P Biotech ETF (XBI.US)$ 95

1

Moomoo Learn

Sep 6 03:05

Columns Navigating the wave of lower interest rates

Given the strong market expectations for a Federal Reserve rate cut, as indicated by the CME data with a 57% chance for a 25-basis-point reduction and a 43% chance for a 50-basis-point cut in September, investors are poised to reconsider their strategies.
With the Fed's September meeting likely to deliver a rate decrease, the question arises: how should investors allocate assets during an interest rate cut cycle? Let's delve into the tactics and consid...

+1

CPI hits 3-year low: How will it sway the Fed rate decision?

15

3

23

frankinglily

Aug 25 22:03

Argument:
The upcoming interest rate cuts are poised to benefit the biotech stock industry, setting the stage for strong performance in the coming quarters.
Reasons:
Cheaper Funding: Lower interest rates make it easier for biotech companies to access capital for research and development, accelerating their progress and growth potential.
Attractive Valuations: Biotech stocks are currently trading at attractive levels, offering investors an opportunity to capitalize on the sector's long-term pot...

Powell said it's time to cut: Will the market go wild?

5

1

XBI SPDR S&P Biotech ETF

Trade Overview

Capital Trend

News

Comments